Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Dow
Mallinckrodt
Colorcon
Moodys
McKesson
Merck

Last Updated: December 9, 2019

DrugPatentWatch Database Preview

Litigation Details for AbbVie Inc. v. Amgen Inc. (D. Del. 2016)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

AbbVie Inc. v. Amgen Inc. (D. Del. 2016)

Docket   Start Trial Date Filed 2016-08-04
Court District Court, D. Delaware Date Terminated 2017-09-28
Cause 35:271 Patent Infringement Assigned To Sue Lewis Robinson
Jury Demand None Referred To
Parties ABBVIE BIOTECHNOLOGY LTD.; ABBVIE INC.; AMGEN INC.; AMGEN MANUFACTURING LTD.
Patents 8,231,876; 8,663,945; 8,715,664; 8,808,700; 8,883,156; 8,889,136; 8,895,009; 8,906,372; 8,906,373; 8,906,646; 8,911,964; 8,916,153; 8,926,975; 8,961,973; 8,961,974; 8,986,693; 8,999,337; 9,018,361; 9,061,005; 9,067,992; 9,073,988; 9,085,618; 9,085,620; 9,090,689; 9,090,867; 9,096,666; 9,102,723; 9,150,645; 9,187,559; 9,200,069; 9,200,070; 9,206,390; 9,234,032; 9,234,033; 9,255,143; 9,266,949; 9,273,132; 9,284,370; 9,284,371; 9,290,568; 9,315,574; 9,328,165; 9,334,319; 9,346,879; 9,359,434; 9,365,645
Attorneys Amanda K. Antons; Amanda L. Major; Amy K. Wigmore; Andrei Harasymiak; Arianna Evers; Benjamin J. Schladweiler; Casey L. Dwyer; Charles S. Marion; Daniel M. Silver; David N. Greenwald; David P. Frazier; Evan R. Chesler; Gabrielle LaHatte; James L. Higgins; John R. Labbe; Jonathan R. Davies; Joshua Stern; Kamilah Alexander; Keith R. Hummel; Kevin M. Flowers; Mark H. Izraelewicz; Melanie K. Sharp; Michael A. Morin; Michael P. Kelly; Nicholas D. Mozal; Sharonmoyee Goswami; Terry Kearney; William F. Lee; William G. McElwain; William Raich
Firms Ross Aronstam & Moritz LLP; Young, Conaway, Stargatt & Taylor LLP
Link to Docket External link to docket
Biologic Drugs cited in AbbVie Inc. v. Amgen Inc.

The biologic drugs covered by the patents cited in this case are   Start Trial ,   Start Trial , and   Start Trial .

Details for AbbVie Inc. v. Amgen Inc. (D. Del. 2016)

Date Filed Document No. Description Snippet Link To Document
2016-08-04 1 Composition 9,328,165 Purified Antibody Composition 8,231,876 Purified Antibody Composition 8,663,945 … U.S Patent No. 8,916,157; U.S Patent No. 8,961,973; U.S Patent No. 8,986,693; U.S Patent No. 9,096,666… U.S Patent No. 9,220,781; U.S Patent No. 9,272,041; U.S. Patent No. 9,359,434; and U.S. Patent No. 9,365,645…United States Patent and Trademark Office (“Patent Office”) has granted AbbVie numerous patents which are…of 6 patents each, and the patents-in-suit constitute the compilation of the two lists (2 patents were External link to document
2016-08-04 3 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,663,945; 8,911,964; 8,916,157… 28 September 2017 1:16-cv-00666 830 Patent None District Court, D. Delaware External link to document
2017-04-27 62 owner by assignment of U.S. Patent No. 8,663,945 (“the ’945 Patent”). AbbVie has alleged that … Non-Infringement and Invalidity of U.S. Patent No. 8,663,945 38. Amgen and AML… The ’945 Patent, the ’964 Patent, the ’157 Patent, the ’973 Patent, the ’693 Patent, the …the ’666 Patent, the ’781 Patent, the ’041 Patent, the ’434 Patent, and the ’645 Patent, and each of … the ’945 Patent, the ’964 Patent, the ’157 Patent, the ’973 Patent, the ’693 Patent, the ’666 External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Johnson and Johnson
AstraZeneca
Mallinckrodt
Boehringer Ingelheim
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.